SGLT 2 INHIBITORS

Clinical trials for SGLT 2 INHIBITORS explained in plain language.

Never miss a new study

Get alerted when new SGLT 2 INHIBITORS trials appear

Sign up with your email to follow new studies for SGLT 2 INHIBITORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

Heart stent patients test common diabetes pill to calm inflammation

Disease control Recruiting now

This study is testing if a diabetes drug called empagliflozin can reduce harmful inflammation that occurs after a heart stent procedure. About 100 patients with stable coronary artery disease will take the drug or a placebo for three days before their scheduled stent placement. R…

Matched conditions: SGLT 2 INHIBITORS

Phase: PHASE4 • Sponsor: Hotel Dieu de France Hospital • Aim: Disease control

Last updated Mar 17, 2026 12:55 UTC

SGLT 2 INHIBITORS

Get alerted when new SGLT 2 INHIBITORS trials appear

Heart stent patients test common diabetes pill to calm inflammation